Case Report: A case of COL1A1 - PDGFB fusion uterine sarcoma at cervix and insights into the clinical management of rare uterine sarcoma.

Frontiers in oncology(2023)

引用 2|浏览6
暂无评分
摘要
- gene fusion uterine sarcoma is an especially rare malignant mesenchymal tumor that was previously classified as an undifferentiated uterine sarcoma due to the lack of specific features of differentiation. Till now, only five cases have been reported, and here we presented another case recently diagnosed in a Chinese woman who had vaginal bleeding. She presented with a cervical mass at the anterior lip of the cervix invading the vagina and was treated with laparoscopic total hysterectomy plus bilateral salpingo-oophorectomy (TH+BSO) and partial vaginal wall resection with the final pathology of - fusion uterine sarcoma. Our aim is to emphasize the importance of differential diagnosis of this rare tumor, as early precise diagnosis may allow patients to benefit from the targeted therapy imatinib. This article also serves as further clinical evidence of this disease, serving to increase clinical awareness of this rare sarcoma to avoid misdiagnosis.
更多
查看译文
关键词
COL1A1-PDGFB fusion,NTRK fusion,RNA sequencing,dermatofibrosarcoma protuberans (DFSP),target therapy,uterine sarcoma
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要